RNAseq

BIOLOGICAL3 trials

Sponsors

George Washington University, Groupe Francais De Pneumo-Cancerologie, University Hospital, Toulouse

Conditions

ALK Gene Rearrangement PositiveALK-Positive Anaplastic Large Cell LymphomaHIV InfectionsImmune ToleranceLTBI - Latent Tuberculosis InfectionNeonatal InfectionNon-small Cell Lung Cancer

Unknown Phase

Immune Response to BCG Vaccination in Neonates Born to HIV and LTBI Infected and Non-infected Mothers

CompletedNCT03383211

George Washington UniversityHIV Infections, Immune Tolerance, LTBI - Latent Tuberculosis Infection +1

Start: 2017-06-16End: 2021-06-30Updated: 2021-10-20

Analysis of Biological Characteristics of Advanced ALK-rearranged NSCLC

RecruitingNCT05122806

Groupe Francais De Pneumo-CancerologieALK Gene Rearrangement Positive, Non-small Cell Lung Cancer

Start: 2021-09-22End: 2027-06-30Target: 100Updated: 2026-04-29

Deciphering the Role of Circular RNAs in ALKpositive Anaplastic Large-cell Lymphoma

University Hospital, ToulouseALK-Positive Anaplastic Large Cell Lymphoma

Start: 2023-01-01End: 2025-12-31Updated: 2023-07-06